Ginger phytochemicals mitigate the obesogenic effects of a high-fat diet in mice: A proteomic and biomarker network analysis

Molecular Nutrition and Food Research

Volumn 55, Issue SUPPL. 2, 2011, Pages

  Beattie, John H ^a   Nicol, Fergus ^a   Gordon, Margaret Jane ^a   Reid, Martin D ^a   Cantlay, Louise ^a   Horgan, Graham W ^b   Kwun, In Sook ^c   Ahn, Ji Yun ^d   Ha, Tae Youl ^d  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b BIOMATHEMATICS AND STATISTICS SCOTLAND   (United Kingdom)

^c Andong National University   (South Korea)

^d Korea Food Research Institute   (South Korea)

Author keywords

6 Gingerol; Correlation network; Obesity; Proteomics; Zerumbone

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ANTIOBESITY AGENT; BIOLOGICAL MARKER; CATECHOL DERIVATIVE; CHOLESTEROL; ENOYL COENZYME A HYDRATASE; FATTY ALCOHOL; GERANYLTRANSFERASE; GINGEROL; PLANT EXTRACT; PROTEIN; SESQUITERPENE; ZERUMBONE;

ALPINIA; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; GINGER; LIPID DIET; LIVER; LOW FAT DIET; METABOLISM; MOUSE; OBESITY; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS;

ACETYL-COA C-ACYLTRANSFERASE; ADIPOSITY; ALPINIA; ANIMALS; ANTI-OBESITY AGENTS; BIOLOGICAL MARKERS; BODY WEIGHT; CATECHOLS; CHOLESTEROL; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; ENOYL-COA HYDRATASE; FATTY ALCOHOLS; GERANYLTRANSTRANSFERASE; GINGER; LIVER; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; PRINCIPAL COMPONENT ANALYSIS; PROTEINS; PROTEOMICS; SESQUITERPENES;

ALPINIA OFFICINARUM; MUS; ZINGIBER OFFICINALE;

EID: 80053289637     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100193     Document Type: Article

References (41)

1. OECD. Obesity and the Economics of Prevention: Fit not Fat. OECD, 2010.
2. Chan, R. S., Woo, J., Prevention of overweight and obesity: how effective is the current public health approach. Int. J. Environ. Res. Public Health 2010, 7, 765-783.
3. McAlpine, D. E., Frisch, M. J., Rome, E. S., Clark, M. M. et al., Bariatric surgery: a primer for eating disorder professionals. Eur. Eat. Disord. Rev. 2010, 18, 304-317.
4. Burch, J., McKenna, C., Palmer, S., Norman, G. et al., Rimonabant for the treatment of overweight and obese people. Health Technol. Assess. 2009, 13, 13-22.
5. Greenway, F. L., Bray, G. A., Combination drugs for treating obesity. Curr. Diab. Rep. 2010, 10, 108-115.
6. Hasani-Ranjbar, S., Nayebi, N., Larijani, B., Abdollahi, M., A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J. Gastroenterol. 2009, 15, 3073-3085.
7. Aggarwal, B. B., Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr. 2010, 30, 173-199.
8. Han, L. K., Gong, X. J., Kawano, S., Saito, M. et al., Antiobesity actions of Zingiber officinale Roscoe. Yakugaku Zasshi 2005, 125, 213-217.
9. Ernst, E., Pittler, M. H., Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br. J. Anaesth. 2000, 84, 367-371.
10. Shukla, Y., Singh, M., Cancer preventive properties of ginger: a brief review. Food Chem. Toxicol. 2007, 45, 683-690.
11. Surh, Y., Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 1999, 428, 305-327.
12. Kitayama, T., Okamoto, T., Hill, R. K., Kawai, Y. et al., Chemistry of zerumbone. 1. Simplified isolation, conjugate addition reactions, and a unique ring contracting transannular reaction of its dibromide. J. Org. Chem. 1999, 64, 2667-2672.
13. Kitayama, T., Yamamoto, K., Utsumi, R., Takatani, M. et al., Chemistry of zerumbone. 2. Regulation of ring bond cleavage and unique antibacterial activities of zerumbone derivatives. Biosci. Biotechnol. Biochem. 2001, 65, 2193-2199.
14. Kim, M., Miyamoto, S., Yasui, Y., Oyama, T. et al., Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int. J. Cancer 2009, 124, 264-271.
15. Wiseman, N., English-Chinese Chinese-English Dictionary of Chinese Medicine, Hunan Scin & Tech Press, P. R. China 2006.
16. Lee, H. S., Cha, M. R., Choi, C. W., Kim, Y. S. et al., Anti-proliferative effect of the rhizome extract of Alpinia officinarum on cultured human tumor cell lines. Kor. J. Pharmacogn. 2008, 39, 347-351.
17. Wang, W., Li, C. Y., Wen, X. D., Li, P., Qi, L. W., Plasma pharmacokinetics, tissue distribution and excretion study of 6-gingerol in rat by liquid chromatography-electrospray ionization time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 2009, 49, 1070-1074.
18. -/- mice. J. Proteome. Res. 2007, 6, 4041-4054.
19. Beattie, J. H., Gordon, M. J., Rucklidge, G. J., Reid, M. D. et al., Aorta protein networks in marginal and acute zinc deficiency. Proteomics 2008, 8, 2126-2135.
20. George, S., Brat, P., Alter, P., Amiot, M. J., Rapid determination of polyphenols and vitamin C in plant-derived products. J. Agric. Food Chem. 2005, 53, 1370-1373.
21. Naczk, M., Shahidi, F., Extraction and analysis of phenolics in food. J. Chromatogr. A 2004, 1054, 95-111.
22. Folch, J., Lees, M., Stanley, G., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
23. Zellner, M., Winkler, W., Hayden, H., Diestinger, M. et al., Quantitative validation of different protein precipitation methods in proteome analysis of blood platelets. Electrophoresis 2005, 26, 2481-2489.
24. Eldershaw, T. P., Colquhoun, E. Q., Dora, K. A., Peng, Z. C., Clark, M. G., Pungent principles of ginger (Zingiber officinale) are thermogenic in the perfused rat hindlimb. Int. J. Obes. Relat. Metab. Disord. 1992, 16, 755-763.
25. Ueki, S., Miyoshi, M., Shido, O., Hasegawa, J., Watanabe, T., Systemic administration of [6]-gingerol, a pungent constituent of ginger, induces hypothermia in rats via an inhibitory effect on metabolic rate. Eur. J. Pharmacol. 2008, 584, 87-92.
26. Henry, C. J., Piggott, S. M., Effect of ginger on metabolic rate. Hum. Nutr. Clin. Nutr. 1987, 41, 89-92.
27. Dedov, V. N., Tran, V. H., Duke, C. C., Connor, M. et al., Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br. J. Pharmacol. 2002, 137, 793-798.
28. Romanovsky, A. A., Almeida, M. C., Garami, A., Steiner, A. A. et al., The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol. Rev. 2009, 61, 228-261.
29. Friedman, J. M., Obesity: causes and control of excess body fat. Nature 2009, 459, 340-342.
30. Szkopinska, A., Plochocka, D., Farnesyl diphosphate synthase; regulation of product specificity. Acta Biochim. Pol. 2005, 52, 45-55.
31. Le Jossic-Corcos, C., Pastori, G. M., Duclos, S., Kawabe, Y. et al., Peroxisome proliferator-activated receptor alpha (PPARalpha) activators induce hepatic farnesyl diphosphate synthase gene expression in rodents. J. Steroid Biochem. Mol. Biol. 2004, 88, 203-211.
32. Ericsson, J., Jackson, S. M., Lee, B. C., Edwards, P. A., Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc. Natl. Acad. Sci. USA 1996, 93, 945-950.
33. Remick, J., Weintraub, H., Setton, R., Offenbacher, J. et al., Fibrate therapy: an update. Cardiol. Rev. 2008, 16, 129-141.
34. Pye, V. E., Christensen, C. E., Dyer, J. H., Arent, S., Henriksen, A., Peroxisomal plant 3-ketoacyl-CoA thiolase structure and activity are regulated by a sensitive redox switch. J. Biol. Chem. 2010, 285, 24078-24088.
35. Yoon, M., The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions. Pharmacol. Res. 2009, 60, 151-159.
36. Chou, C. J., Haluzik, M., Gregory, C., Dietz, K. R. et al., WY14, 643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J. Biol. Chem. 2002, 277, 24484-24489.
37. Vassileva, G., Huwyler, L., Poirier, K., Agellon, L. B., Toth, M. J., The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J. 2000, 14, 2040-2046.
38. Pei, Z., Jia, Z., Watkins, P. A., The second member of the human and murine bubblegum family is a testis- and brainstem-specific acyl-CoA synthetase. J. Biol. Chem. 2006, 281, 6632-6641.
39. Yang, Y., Sharma, R., Zimniak, P., Awasthi, Y. C., Role of alpha class glutathione S-transferases as antioxidant enzymes in rodent tissues. Toxicol. Appl. Pharmacol. 2002, 182, 105-115.
40. Browne, G. J., Proud, C. G., Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 2002, 269, 5360-5368.
41. Koike, E., Toda, S., Yokoi, F., Izuhara, K. et al., Expression of new human inorganic pyrophosphatase in thyroid diseases: its intimate association with hyperthyroidism. Biochem. Biophys. Res. Commun. 2006, 341, 691-696.